Identifying Barriers and Facilitators to Pain Management With Buprenorphine for Patients With Kidney Failure: A Thematic Analysis of Interviews With Key Partners
Significant barriers to effective pain management and access to buprenorphine exist for patients with kidney failure at multiple levels (ie, patient, provider, organization, and systems levels). Therefore, multilevel interventions that include components that target patient stigma, clinician education, and increase collaboration among key partners are needed.
Authors
- Cramer J. Kallem (ORCID: https://orcid.org/0000-0002-4835-0363)
- Megan Hamm (ORCID: https://orcid.org/0000-0002-7842-5290)
- Manisha Jhamb (ORCID: https://orcid.org/0000-0002-9178-1468)
- Donna Olejniczak
- Karlyn A. Edwards (ORCID: https://orcid.org/0000-0002-5821-3733)
- Nwamaka D. Eneanya
- Hailey W. Bulls (ORCID: https://orcid.org/0000-0003-1005-0303)
- Jane M. Liebschutz (ORCID: https://orcid.org/0000-0003-3492-1521)
- Kerri L. Cavanaugh (ORCID: https://orcid.org/0000-0002-4031-1714)
- Flor de Abril Cameron (ORCID: https://orcid.org/0000-0002-4079-4744)
- Caroline Wilkie
Institutions
- Emory University (US)
- University of Pittsburgh (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Kidney Medicine
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.xkme.2025.101130
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00